Medicine and Dentistry
Child
66%
Psoriasis
64%
Pediatrics Patient
51%
Dermatology Life Quality Index
44%
Telemedicine
44%
Acrodermatitis Enteropathica
44%
Apremilast
44%
Congenital Syphilis
44%
Capillary Hemangioma
38%
Clearance
33%
False Negative Result
33%
Evaluation Study
31%
Photograph
31%
Psoriasis Area and Severity Index
31%
Therapeutic Procedure
26%
Age
26%
Infant
26%
Skin
22%
Cyclosporine
22%
Coal Tar
22%
Prenatal Care
22%
Syphilis
22%
Neonatal Infant
22%
COVID-19
19%
Psoriasis Vulgaris
18%
Zinc
17%
Lesion
17%
Supplementation
17%
Patient
15%
Methotrexate
14%
Adalimumab
14%
B-Cell Lymphoma
14%
Lymphoma
14%
Pharmacokinetics
13%
Cross Sectional Study
12%
Interpersonal Communication
12%
Experience
12%
Physician
12%
Assessment
11%
Scalp
11%
Screening Test
11%
Prevalence
11%
Public Health
11%
Clinical Finding
11%
Adolescent
8%
Adult
8%
Taste
8%
Human Milk
8%
Nausea and Vomiting
8%
Alopecia Mucinosa
8%
Nursing and Health Professions
Alefacept
100%
Psoriasis
97%
Patient
77%
Biological Product
54%
Dermatology Life Quality Index
44%
Infliximab
44%
Psoriasis Area and Severity Index
40%
Clearance
33%
Intralesional Drug Administration
26%
Adalimumab
25%
Inpatient
22%
Ciclosporin
22%
Dithranol
22%
Coal Tar
22%
Quality of Life
16%
Procedures
15%
Psoriasis Vulgaris
15%
Methotrexate
14%
Lymphoma
14%
B Cell Lymphoma
14%
Dose
12%
Patient-Reported Outcome
11%
Pilot Study
11%
Adult
11%
Family
11%
Ixekizumab
11%
Pustulosis palmoplantaris
11%
Scalp Psoriasis
11%
Physician
11%
Time
11%
Drug Therapy
11%
Etanercept
11%
Calcipotriol
11%
Sample Size
10%
Literature Review
7%
Drug Megadose
7%
Monotherapy
7%
Dermatological Agent
7%
Transplantation
7%
Low Drug Dose
7%
Standard
5%
Control
5%
Interleukin 17
5%
Pediatrics
5%
Monoclonal Antibody
5%
Nail Psoriasis
5%
Psoriasis Severity Index
5%
Maintenance Therapy
5%
Food and Drug Administration
5%
Follow up
5%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
57%
Apremilast
44%
Santalum Album
44%
Clobetasol Propionate
44%
Oil
44%
Apremilast
44%
Psoriasis Vulgaris
44%
Coal Tar
22%
Ciclosporin
22%
Eczema
16%
Phosphodiesterase
16%
B Cell Lymphoma
14%
Methotrexate
14%
Shampoo
14%
Calcipotriol
14%
Adalimumab
14%
Lymphoma
14%
Case Report
14%
Pharmacokinetics
13%
Psoriasis Vulgaris
13%
Dermatitis
11%
Atopic Dermatitis
11%
Anti-Inflammatory Drug
11%
Immunoglobulin Enhancer Binding Protein
11%
Cytokine
11%
Betamethasone
7%
Dermatological Agent
7%
Monotherapy
7%
Topical Agent
7%
Betamethasone Dipropionate Plus Calcipotriol
7%
Betamethasone Dipropionate
7%
Phosphodiesterase Inhibitor
5%
Malignant Neoplasm
5%
Cyclic AMP Phosphodiesterase
5%
Lipopolysaccharide
5%
Diseases
5%
Chemokine
5%